235 related articles for article (PubMed ID: 29343199)
21. Density of tumor-associated macrophages (TAMs) and expression of their growth factor receptor MCSF-R and CD14 in canine mammary adenocarcinomas of various grade of malignancy and metastasis.
Król M; Pawłowski KM; Majchrzak K; Dolka I; Abramowicz A; Szyszko K; Motyl T
Pol J Vet Sci; 2011; 14(1):3-10. PubMed ID: 21528705
[TBL] [Abstract][Full Text] [Related]
22. Low density of CD204-positive M2-type tumor-associated macrophages in Epstein-Barr virus-associated gastric cancer: a clinicopathologic study with digital image analysis.
Ichimura T; Abe H; Morikawa T; Yamashita H; Ishikawa S; Ushiku T; Seto Y; Fukayama M
Hum Pathol; 2016 Oct; 56():74-80. PubMed ID: 27342912
[TBL] [Abstract][Full Text] [Related]
23. Analysis of Hypoxia-Inducible Factor-1α Expression Relative to Other Key Factors in Malignant Canine Mammary Tumours.
Shin JI; Lim HY; Kim HW; Seung BJ; Sur JH
J Comp Pathol; 2015; 153(2-3):101-10. PubMed ID: 26145724
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
[TBL] [Abstract][Full Text] [Related]
25. Expression and the molecular forms of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase 9 in canine mammary tumours.
Chen YC; Chang SC; Huang YH; Lee YJ; Chang CC; Liao JW; Hsu WL
Vet Comp Oncol; 2019 Sep; 17(3):427-438. PubMed ID: 31050171
[TBL] [Abstract][Full Text] [Related]
26. Expression frequency of c-kit isoforms and its prognostic potential in canine mammary tumours.
Chen YC; Liao JW; Chang SC; Hsu WL
Vet Comp Oncol; 2020 Sep; 18(3):303-314. PubMed ID: 31652393
[TBL] [Abstract][Full Text] [Related]
27. Pathological classification of canine mammary tumor based on quantifying mRNA levels of hormonal receptors, SATB1, and Snail in tissue and fine needle biopsy samples.
Komatsu T; Iwano H; Ebisawa M; Watabe A; Endo Y; Hirayama K; Taniyama H; Kadosawa T
J Vet Med Sci; 2012 Jun; 74(6):719-26. PubMed ID: 22230980
[TBL] [Abstract][Full Text] [Related]
28. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
29. The class A macrophage scavenger receptor CD204 is a useful immunohistochemical marker of canine histiocytic sarcoma.
Kato Y; Murakami M; Hoshino Y; Mori T; Maruo K; Hirata A; Nakagawa TL; Yanai T; Sakai H
J Comp Pathol; 2013 Feb; 148(2-3):188-96. PubMed ID: 22901707
[TBL] [Abstract][Full Text] [Related]
30. Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma.
Ohtaki Y; Ishii G; Nagai K; Ashimine S; Kuwata T; Hishida T; Nishimura M; Yoshida J; Takeyoshi I; Ochiai A
J Thorac Oncol; 2010 Oct; 5(10):1507-15. PubMed ID: 20802348
[TBL] [Abstract][Full Text] [Related]
31. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
[TBL] [Abstract][Full Text] [Related]
32. Tumor-associated macrophages in canine visceral hemangiosarcoma.
Kerboeuf M; Haugeberg DA; Olsen T; Sørling LK; Koppang EO; Moe L; Haaland AH
Vet Pathol; 2024 Jan; 61(1):32-45. PubMed ID: 37341055
[TBL] [Abstract][Full Text] [Related]
33. The relationship between basal and luminal cytokeratins with histopathologic characteristics of canine mammary gland cancer.
Eivani D; Mortazavi P
Pol J Vet Sci; 2016; 19(2):261-9. PubMed ID: 27487499
[TBL] [Abstract][Full Text] [Related]
34. Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study.
Canadas A; França M; Pereira C; Vilaça R; Vilhena H; Tinoco F; Silva MJ; Ribeiro J; Medeiros R; Oliveira P; Dias-Pereira P; Santos M
Vet Pathol; 2019 Mar; 56(2):208-219. PubMed ID: 30381007
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical expression of vascular endothelial growth factor in canine mammary tumours.
Santos AA; Oliveira JT; Lopes CC; Amorim IF; Vicente CM; Gärtner FR; Matos AJ
J Comp Pathol; 2010 Nov; 143(4):268-75. PubMed ID: 20570280
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study.
Santos A; Lopes C; Frias C; Amorim I; Vicente C; Gärtner F; Matos Ad
Vet J; 2011 Dec; 190(3):396-402. PubMed ID: 21269852
[TBL] [Abstract][Full Text] [Related]
37. Significance of caveolin-1 and matrix metalloproteinase 14 gene expression in canine mammary tumours.
Ebisawa M; Iwano H; Nishikawa M; Tochigi Y; Komatsu T; Endou Y; Hirayama K; Taniyama H; Kadosawa T; Yokota H
Vet J; 2015 Nov; 206(2):191-6. PubMed ID: 26364240
[TBL] [Abstract][Full Text] [Related]
38. Expression of HER-2 and nuclear localization of HER-3 protein in canine mammary tumors: histopathological and immunohistochemical study.
Kim JH; Im KS; Kim NH; Yhee JY; Nho WG; Sur JH
Vet J; 2011 Sep; 189(3):318-22. PubMed ID: 20947393
[TBL] [Abstract][Full Text] [Related]
39. Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors.
Spoerri M; Guscetti F; Hartnack S; Boos A; Oei C; Balogh O; Nowaczyk RM; Michel E; Reichler IM; Kowalewski MP
BMC Vet Res; 2015 Sep; 11():235. PubMed ID: 26370564
[TBL] [Abstract][Full Text] [Related]
40. Canine Spindle Cell Mammary Tumor: A Retrospective Study of 67 Cases.
Alonso-Diez Á; Ramos A; Roccabianca P; Barreno L; Pérez-Alenza MD; Tecilla M; Avallone G; Gama A; Peña L
Vet Pathol; 2019 Jul; 56(4):526-535. PubMed ID: 30857503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]